Riyom Clinical Trials Private Limited
About Riyom Clinical Trials Private Limited
Data last updated:
Riyom Clinical Trials Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical elements and compounds doped segment of the chemicals sector. It was incorporated on 18 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24296DL2019PTC356371.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankur Bajpai and Satya Prakash Yadav.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Z – 20 Between 18 To 23 Okhla Indl. Area Ph – 2 Near Main Road, New Delhi, Delhi, India – 110020.
Company details
Contact details
Riyom Clinical Trials Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressZ – 20 Between 18 To 23 Okhla Indl. Area Ph – 2 Near Main Road, New Delhi, Delhi, India – 110020
- IndustryChemicals, Chemical Elements And Compounds Doped, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Riyom Clinical Trials Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Riyom Clinical Trials Private Limited, buy the company report.
Board of directors of Riyom Clinical Trials Private Limited
Riyom Clinical Trials has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Bajpai | Director | 18 Oct 2019 | 7 Years 0 Months | Current |
| Satya Prakash Yadav | Director | 18 Oct 2019 | 7 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Riyom Clinical Trials Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riyom Clinical Trials Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Riyom Clinical Trials Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Riyom Clinical Trials Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ankur Bajpai was appointed as Director on 18 Oct 2019.
Frequently asked questions
Riyom Clinical Trials is an active private limited company based in New Delhi, Delhi, India. The company works in chemical elements and compounds doped, within the chemicals industry. It was incorporated on 18 October 2019 (7+ years old) and is registered under CIN U24296DL2019PTC356371.
Riyom Clinical Trials has 2 current directors:
- Ankur Bajpai - Director
- Satya Prakash Yadav - Director
The latest financial statements of Riyom Clinical Trials on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Riyom Clinical Trials is U24296DL2019PTC356371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riyom Clinical Trials was incorporated on 18 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Ankur Bajpai was appointed as Director on 18 Oct 2019. Satya Prakash Yadav was appointed as Director on 18 Oct 2019.
The registered office of Riyom Clinical Trials is at Z – 20 Between 18 To 23 Okhla Indl. Area Ph – 2 Near Main Road, New Delhi, Delhi, India – 110020.
Riyom Clinical Trials operates in the chemicals industry, in the chemical elements and compounds doped segment.
Riyom Clinical Trials can be reached at its registered office: Z – 20 Between 18 To 23 Okhla Indl. Area Ph – 2 Near Main Road, New Delhi, Delhi, India – 110020.
Riyom Clinical Trials is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
